"Mice, Nude" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.
| Descriptor ID |
D008819
|
| MeSH Number(s) |
B01.050.150.900.649.313.992.635.505.500.550.500
|
| Concept/Terms |
Mice, Nude- Mice, Nude
- Athymic Mice
- Mouse, Nude
- Nude Mouse
- Nude Mice
- Mouse, Athymic
- Athymic Mouse
- Mice, Athymic
|
Below are MeSH descriptors whose meaning is more general than "Mice, Nude".
Below are MeSH descriptors whose meaning is more specific than "Mice, Nude".
This graph shows the total number of publications written about "Mice, Nude" by people in this website by year, and whether "Mice, Nude" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 9 | 9 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 8 | 8 |
| 2000 | 0 | 9 | 9 |
| 2001 | 0 | 4 | 4 |
| 2002 | 0 | 12 | 12 |
| 2003 | 0 | 7 | 7 |
| 2004 | 0 | 7 | 7 |
| 2005 | 0 | 13 | 13 |
| 2006 | 0 | 11 | 11 |
| 2007 | 0 | 12 | 12 |
| 2008 | 0 | 12 | 12 |
| 2009 | 0 | 18 | 18 |
| 2010 | 0 | 17 | 17 |
| 2011 | 0 | 26 | 26 |
| 2012 | 0 | 23 | 23 |
| 2013 | 0 | 25 | 25 |
| 2014 | 0 | 31 | 31 |
| 2015 | 0 | 22 | 22 |
| 2016 | 0 | 30 | 30 |
| 2017 | 0 | 19 | 19 |
| 2018 | 0 | 24 | 24 |
| 2019 | 0 | 20 | 20 |
| 2020 | 0 | 19 | 19 |
| 2021 | 0 | 17 | 17 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 3 | 4 |
| 2025 | 0 | 10 | 10 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mice, Nude" by people in Profiles.
-
Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth. Mol Cancer Ther. 2026 Feb 04; 25(2):257-271.
-
Dual targeting of AMRC12 and Malassezia globosa disrupts MYC liquid condensates-driven nuclear pore complex biogenesis in neuroblastoma. Theranostics. 2026; 16(6):2866-2886.
-
Re/99mTc Tricarbonyl Phenformin Complexes Targeting Mitochondria as Pancreatic Cancer Theranostics. J Med Chem. 2025 Nov 13; 68(21):22818-22830.
-
Acrolein-induced PKM2 modification drives NETosis and glioma progression. Free Radic Biol Med. 2025 Dec 16; 241:567-581.
-
SLC44A2 negatively regulates mitochondrial fatty acid oxidation to suppress colorectal progression by blocking the MUL1-CPT2 interaction. Cell Death Dis. 2025 Jul 01; 16(1):468.
-
Polo-like kinase 1 inactivation enhances PI3K inhibition-mediated apoptosis of NOTCH1-mutant head and neck squamous cell carcinoma. Cancer Lett. 2025 Aug 10; 625:217814.
-
Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma. Int J Med Sci. 2025; 22(10):2488-2501.
-
Regulating chemoresistance and cancer stemness: the CDH17-YAP pathway in distinct cellular states of lung cancer CTC clusters. Cell Mol Biol Lett. 2025 Feb 24; 30(1):23.
-
Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2-positive breast cancer. Br J Pharmacol. 2025 Jun; 182(11):2524-2541.
-
Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Rep Med. 2025 Feb 18; 6(2):101941.